WallStreetZenWallStreetZen

NASDAQ: EYPT
Eyepoint Pharmaceuticals Inc Stock Ownership - Who owns Eyepoint Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Eyepoint Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jay S. DukerPresident and CEO2026-01-0610,054$16.86
$169.51kSell
George ElstonChief Financial Officer2026-01-064,487$16.86
$75.65kSell
Ramiro RibeiroChief Medical Officer2026-01-0529,250$8.26
$241.61kBuy
George ElstonChief Financial Officer2026-01-054,403$17.43
$76.74kSell
Ramiro RibeiroChief Medical Officer2026-01-0542,544$17.10
$727.33kSell
Jay S. DukerPresident and CEO2026-01-0514,505$17.43
$252.82kSell
George ElstonChief Financial Officer2026-01-036,324$17.48
$110.54kSell
Ramiro RibeiroChief Medical Officer2026-01-036,373$17.48
$111.40kSell
Jay S. DukerPresident and CEO2026-01-0323,447$17.48
$409.85kSell
Cormorant Asset Management LPInsider2025-12-0460,000$15.70
$942.24kSell

1 of 3

EYPT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EYPT insiders and whales buy or sell their stock.

EYPT Shareholders

What type of owners hold Eyepoint Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ew Healthcare Partners LP105.45%87,298,833$1.18BInsider
Pfizer Inc89.97%74,483,748$1.01BInsider
Ronald W. Eastman20.79%17,212,648$232.72MInsider
Cormorant Asset Management LP20.04%16,590,000$224.30MInsider
Cormorant Asset Management LP10.06%8,325,000$112.55MInstitution
Suvretta Capital Management LLC7.48%6,192,715$83.73MInstitution
Adage Capital Partners GP LLC6.72%5,559,782$75.17MInstitution
Adage Capital Management LP6.23%5,156,299$69.71MInsider
Blackrock Inc6.00%4,964,526$67.12MInstitution
Federated Hermes Inc5.33%4,416,332$59.71MInstitution

1 of 3

EYPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EYPT25.47%74.53%Net SellingNet Selling
INBX71.92%28.08%Net Selling
CMPX78.54%21.46%Net SellingNet Buying
SVRA39.35%60.65%Net SellingNet Selling
DAWN57.43%42.57%Net SellingNet Selling
View Top Biotech Stocks

Eyepoint Pharmaceuticals Stock Ownership FAQ

Who owns Eyepoint Pharmaceuticals?

Eyepoint Pharmaceuticals (NASDAQ: EYPT) is owned by 83.79% institutional shareholders, 245.21% Eyepoint Pharmaceuticals insiders, and 0.00% retail investors. Ew Healthcare Partners LP is the largest individual Eyepoint Pharmaceuticals shareholder, owning 87.30M shares representing 105.45% of the company. Ew Healthcare Partners LP's Eyepoint Pharmaceuticals shares are currently valued at $1.18B.

If you're new to stock investing, here's how to buy Eyepoint Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.